These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 26159020
1. [Efficacy of Chinese Herbs for Supplementing Qi and Activating Blood Circulation on Patients with Acute Coronary Syndrome and Type 2 Diabetes Mellitus after Percutaneous Coronary Intervention: a Clinical Observation]. Du JP, Wang CL, Wang PL, Wang SL, Gao ZY, Zhang DW, Xu H, Shi DZ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 May; 35(5):563-7. PubMed ID: 26159020 [Abstract] [Full Text] [Related]
2. Protective effect of Chinese herbs for supplementing qi, nourishing yin and activating blood circulation on heart function of patients with acute coronary syndrome after percutaneous coronary intervention. Liu HY, Wang W, Shi DZ, Ge JB, Zhang L, Peng J, Wang CL, Wang PL. Chin J Integr Med; 2012 Jun; 18(6):423-30. PubMed ID: 22382523 [Abstract] [Full Text] [Related]
3. Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial. Wang PL, Zhang L, Wang SL, Yang QN, Gao ZY, Du JP, Zhang DW, Fu CG, Gu F, Xu H, Li LZ, Wang CL, Shi DZ. Chin J Integr Med; 2017 Oct; 23(10):740-746. PubMed ID: 27778264 [Abstract] [Full Text] [Related]
4. The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention. Zhang DW, Wang SL, Wang PL, Du JP, Gao ZY, Wang CL, Xu H, Shi DZ. J Ethnopharmacol; 2020 Feb 10; 248():112354. PubMed ID: 31689480 [Abstract] [Full Text] [Related]
5. [Effect of Tongguan capsule on post-intervention patients of coronary heart disease with qi-deficiency and blood stasis syndrome]. Li J, Zhang MZ, Chen BJ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan 10; 28(1):32-5. PubMed ID: 18418966 [Abstract] [Full Text] [Related]
6. [Intervention of traditional Chinese patent medicine based on syndrome differentiation in female patients after percutaneous coronary intervention due to acute coronary syndrome: a nationwide multicenter prospective cohort study]. Bai RN, Gu F, Cai YJ, Sheng S, Yang QN, Xi RX, Li LZ, Shi DZ. Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Sep 24; 52(9):1073-1080. PubMed ID: 39289998 [Abstract] [Full Text] [Related]
7. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention]. Chen ZQ, Hong L, Wang H, Yin QL. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr 24; 36(4):415-20. PubMed ID: 27323611 [Abstract] [Full Text] [Related]
9. [Therapy for replenishing qi, nourishing yin and promoting blood circulation in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial]. Qiu SL, Jin M, Yi JH, Zhu TG, Quan X, Liang Y. Zhong Xi Yi Jie He Xue Bao; 2009 Jul 24; 7(7):616-21. PubMed ID: 19615314 [Abstract] [Full Text] [Related]
10. [Effect of tongxinluo capsule on platelet activities and vascular endothelial functions as well as prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention]. Chen ZQ, Hong L, Wang H. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr 24; 31(4):487-91. PubMed ID: 21608219 [Abstract] [Full Text] [Related]
12. A comparative evaluation of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Dasbiswas A, Rao MS, Babu PR, Vijayvergiya R, Nayak R, Dani S, Tyagi S, Hiremath S, Patel T, Alexander T, Prakash VS, Singh DP, Yadav MK, Pathak K, Srivastava A. J Assoc Physicians India; 2013 Feb 24; 61(2):114-6, 126. PubMed ID: 24471250 [Abstract] [Full Text] [Related]
13. [Clinical comprehensive evaluation of Naoxintong Capsules in treatment of cerebral infarction with Qi deficiency and blood stasis syndrome and coronary heart disease angina pectoris]. Geng HJ, Xie YM, Wang ZF. Zhongguo Zhong Yao Za Zhi; 2021 Dec 24; 46(23):6087-6095. PubMed ID: 34951236 [Abstract] [Full Text] [Related]
14. Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial. Guo M, Wang P, Du J, Fu C, Yang Q, Gao Z, Zhu M, Lv S, Deng Y, Li T, Shi D, Working Group FTX. Pharmacol Res; 2020 Aug 24; 158():104883. PubMed ID: 32446979 [Abstract] [Full Text] [Related]
17. Clinical efficacy of traditional chinese medicine on acute myocardial infarction: a prospective cohort study. Duan WH, Lu F, Li LZ, Wang CL, Liu JG, Yang QN, Gu F, Zhang L, Shi DZ. Chin J Integr Med; 2012 Nov 24; 18(11):807-12. PubMed ID: 22898760 [Abstract] [Full Text] [Related]
18. Effectiveness and Safety of Qishen Yiqi Dripping Pill in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: 3-Year Results from a Multicentre Cohort Study. Bai RN, Gu F, Che QZ, Zhang X, Cai YJ, Xi RX, Zhao Y, Guo M, Dong GJ, Gao ZY, Fu CG, Wang PL, Du JP, Zhang DW, Duan WH, Li LZ, Yang QN, Shi DZ. Chin J Integr Med; 2024 Oct 24; 30(10):877-885. PubMed ID: 39172302 [Abstract] [Full Text] [Related]
20. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome. Hao Y, Yang Y, Wang Y, Li J. Curr Med Res Opin; 2022 Oct 24; 38(10):1663-1672. PubMed ID: 35575139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]